Cancer, Treatment-RelatedECOLENCT07652502
Physical Exercise During the Cancer Care Pathway
An observational study of Cancer, Treatment-Related and Cancer, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 2 sites in 2 countries.
Trial summary
Background: Physical exercise is proven safe and effective in improving quality of life and reducing treatment-related side effects in oncology. However, patient adherence to international guidelines remains suboptimal. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cancer, Treatment-Related, Cancer, Oncology
- How many people
- 370 participants
- Where
- 2 sitesin 2 countries
- Study dates
- 15 Jun 2026to 30 Oct 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult cancer patients (≥18 years old), at any stage of the oncological journey (undergoing treatment, posttreatment, or advanced disease).
Who may be able to join
- Age ≥18 years
- Oncological diagnosis
- Ability to understand the language of the respective country of origin
- Electronic informed consent
Who cannot join
- Failure to accept the informed consent
Trial locations and contacts
2 sites in 2 countries. Contact the study team or a site near you to ask about taking part.
2 sites in 2 countries
France1 site
Institut Rafael
Paris, 92300
Nathaniel Scher, nathaniel.scher@gmail.com
Nathaniel Scher
Romania1 site
Universitatea Alexandru Ioa Cuza din Iasi
Iași, 700506
Beatrice Abalasei, beatrice.abalasei@uaic.ro
Beatrice Abalasei
About this study
Background: Physical exercise is proven safe and effective in improving quality of life and reducing treatment-related side effects in oncology. However, patient adherence to international guidelines remains suboptimal. Investigating the knowledge, attitudes, and practices (KAP) regarding physical activity is crucial to identifying unmet educational needs and barriers.
Objective: This multicenter, cross-sectional observational study (ECOLE project) aims to assess KAP levels concerning exercise among cancer patients and explore the correlations between KAP scores and sociodemographic or clinical variables.
Read more
Methods: Over a 6-month period, an anonymous online survey (Microsoft Forms) will be administered to adult cancer patients (≥18 years old) at any disease or treatment stage. A minimum sample size of 370 participants is targeted. Statistical analyses will include Descriptive Statistics, Exploratory and Confirmatory Factor Analyses to validate KAP scales, and Multivariable Logistic Regression to identify predictors of adherence (≥150 minutes/week) and perceived barriers or facilitators.
Expected Results: The study will provide a comprehensive overview of physical activity perceptions and behaviors in oncology. These insights will support the design of targeted educational interventions and structured exercise programs, contributing to the development of a novel "Exercise Oncology Specialist" within supportive care teams.
- Conditions
- Cancer, Treatment-Related, Cancer, Oncology, Oncologic Disorders
- Medical subject headings
- Neoplasms, Second Primary, Neoplasms
What is being measured
The primary outcome is the main question the study is designed to answer.
physical exercise in cancer patients.
To evaluate the level of knowledge, attitudes, and practices (KAP) related to physical by administering the study survey exercise in cancer patients.
Measured: 1 day
Secondary outcomes (6)
safety of physical exercise oncology
Determine the level of knowledge regarding the benefits and safety of physical exercise by administering the study survey.
Measured: 1 day
self-efficacy regarding exercise oncology
Evaluate attitudes, perceptions, and self-efficacy regarding physical activity by administering the study survey.
Measured: 1 day
relationship between exercise oncology and oncological journey
Analyze the potential relationship between knowledge, attitudes, and the practice of physical exercise
Measured: 1 day
demographic and clinical variables in exercise oncology
Explore the role of demographic and clinical variables (e.g., age, sex, tumor type, phase of treatment) by administering the study questionnaire.
Measured: 1 day
barriers and facilitators to exercise oncology
Identify potential barriers and facilitators to the practice of physical exercise by administering the study questionnaire.
Measured: 1 day
interest of cancer patients in exercise oncology
Assess the interest of cancer patients in structured physical exercise programs by administering the study questionnaire.
Measured: 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jun 2026
- Study start15 Jun 2026 (estimated)
- Primary completion15 Dec 2026 (estimated)
- Study completion30 Oct 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cancer, Treatment-RelatedStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 370 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Stefano Magno, Principal investigator, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07652502
- Sponsor's protocol ID
- 27191
- Acronym
- ECOLE
- Status last verified
- Jun 2026
- First submitted
- 11 Jun 2026
- Last updated
- 26 Jun 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Physical Exercise During the Cancer Care Pathway
- ClinicalTrials.gov ID
- NCT07652502
- Acronym / sponsor ID
- ECOLE / 27191
- Conditions
- Cancer, Treatment-Related, Cancer, Oncology, Oncologic Disorders
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 370 participants (estimated)
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCSUniversity, hospital or other
- Study start
- 15 Jun 2026 (estimated)
- Primary completion
- 15 Dec 2026 (estimated)
- Study completion
- 30 Oct 2027 (estimated)
- First posted
- 17 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background: Physical exercise is proven safe and effective in improving quality of life and reducing treatment-related side effects in oncology. However, patient adherence to international guidelines remains suboptimal. Investigating the knowledge, attitudes, and practices (KAP) regarding physical activity is crucial to identifying unmet educational needs and barriers.
Objective: This multicenter, cross-sectional observational study (ECOLE project) aims to assess KAP levels concerning exercise among cancer patients and explore the correlations between KAP scores and sociodemographic or clinical variables.
Methods: Over a 6-month period, an anonymous online survey (Microsoft Forms) will be administered to adult cancer patients (≥18 years old) at any disease or treatment stage. A minimum sample size of 370 participants is targeted. Statistical analyses will include Descriptive Statistics, Exploratory and Confirmatory Factor Analyses to validate KAP scales, and Multivariable Logistic Regression to identify predictors of adherence (≥150 minutes/week) and perceived barriers or facilitators.
Expected Results: The study will provide a comprehensive overview of physical activity perceptions and behaviors in oncology. These insights will support the design of targeted educational interventions and structured exercise programs, contributing to the development of a novel "Exercise Oncology Specialist" within supportive care teams.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult cancer patients (≥18 years old), at any stage of the oncological journey (undergoing treatment, posttreatment, or advanced disease).
Key inclusion criteria (4 listed)
- Age ≥18 years
- Oncological diagnosis
- Ability to understand the language of the respective country of origin
- Electronic informed consent
Key exclusion criteria (1 listed)
- Failure to accept the informed consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
physical exercise in cancer patients.
Time frame: 1 day
To evaluate the level of knowledge, attitudes, and practices (KAP) related to physical by administering the study survey exercise in cancer patients.
6 secondary outcomes
safety of physical exercise oncology
Time frame: 1 day
self-efficacy regarding exercise oncology
Time frame: 1 day
relationship between exercise oncology and oncological journey
Time frame: 1 day
demographic and clinical variables in exercise oncology
Time frame: 1 day
barriers and facilitators to exercise oncology
Time frame: 1 day
interest of cancer patients in exercise oncology
Time frame: 1 day
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jun 2026.
Related trials for Cancer, Treatment-Related
RecruitingPhase 2
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Adjustment Disorder, Adjustment Disorder With Anxious Mood
RecruitingPhase 2
CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
HSIL, High Grade Squamous Intraepithelial Lesion, HPV-Related Squamous Cell Carcinoma
RecruitingPhase 2
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Active, not recruitingPhase 2
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
Anxiety, Depression
RecruitingPhase 2
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Stefano Magno principal investigator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
2 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer, Treatment-Related and Cancer, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 2 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 26 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in France, Romania. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Stefano Magno (+390630157077, stefano.magno@policlinicogemelli.it), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
physical exercise in cancer patients. (time frame: 1 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2026.